nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—NAT2—urinary bladder cancer	0.339	0.606	CbGaD
Dapsone—MPO—urinary bladder cancer	0.16	0.287	CbGaD
Dapsone—MPO—Carboplatin—urinary bladder cancer	0.072	0.259	CbGbCtD
Dapsone—MPO—Cisplatin—urinary bladder cancer	0.0616	0.222	CbGbCtD
Dapsone—PTGS2—urinary bladder cancer	0.0601	0.107	CbGaD
Dapsone—PTGS2—Cisplatin—urinary bladder cancer	0.0213	0.0765	CbGbCtD
Dapsone—PTGS2—Etoposide—urinary bladder cancer	0.0209	0.0752	CbGbCtD
Dapsone—PTGS1—Etoposide—urinary bladder cancer	0.0176	0.0635	CbGbCtD
Dapsone—CYP3A4—Thiotepa—urinary bladder cancer	0.0152	0.0548	CbGbCtD
Dapsone—CYP2E1—Etoposide—urinary bladder cancer	0.0136	0.049	CbGbCtD
Dapsone—CYP2C8—Fluorouracil—urinary bladder cancer	0.0122	0.0439	CbGbCtD
Dapsone—CYP3A5—Etoposide—urinary bladder cancer	0.0106	0.0381	CbGbCtD
Dapsone—NAT2—urine—urinary bladder cancer	0.0104	0.25	CbGeAlD
Dapsone—CYP2C8—Etoposide—urinary bladder cancer	0.0102	0.0366	CbGbCtD
Dapsone—CYP2C9—Fluorouracil—urinary bladder cancer	0.00851	0.0306	CbGbCtD
Dapsone—CYP2C9—Cisplatin—urinary bladder cancer	0.00722	0.026	CbGbCtD
Dapsone—FMO3—urine—urinary bladder cancer	0.00472	0.114	CbGeAlD
Dapsone—Infertility male—Thiotepa—urinary bladder cancer	0.00461	0.143	CcSEcCtD
Dapsone—CYP3A4—Etoposide—urinary bladder cancer	0.00413	0.0149	CbGbCtD
Dapsone—CYP3A4—Doxorubicin—urinary bladder cancer	0.00282	0.0101	CbGbCtD
Dapsone—NAT2—renal system—urinary bladder cancer	0.00254	0.0612	CbGeAlD
Dapsone—Sulfamethoxazole—NAT1—urinary bladder cancer	0.00223	0.761	CrCbGaD
Dapsone—Application site burn—Fluorouracil—urinary bladder cancer	0.0021	0.0652	CcSEcCtD
Dapsone—CYP2C19—urine—urinary bladder cancer	0.00208	0.0502	CbGeAlD
Dapsone—FMO3—prostate gland—urinary bladder cancer	0.00169	0.0408	CbGeAlD
Dapsone—CYP2C9—urine—urinary bladder cancer	0.00162	0.0389	CbGeAlD
Dapsone—CYP2E1—urine—urinary bladder cancer	0.00153	0.0369	CbGeAlD
Dapsone—CYP3A4—urine—urinary bladder cancer	0.00123	0.0297	CbGeAlD
Dapsone—Application site pain—Fluorouracil—urinary bladder cancer	0.001	0.0311	CcSEcCtD
Dapsone—Application site reaction—Fluorouracil—urinary bladder cancer	0.000938	0.0291	CcSEcCtD
Dapsone—CYP2C18—vagina—urinary bladder cancer	0.000869	0.0209	CbGeAlD
Dapsone—FMO3—vagina—urinary bladder cancer	0.000836	0.0201	CbGeAlD
Dapsone—MPO—epithelium—urinary bladder cancer	0.00082	0.0197	CbGeAlD
Dapsone—MPO—renal system—urinary bladder cancer	0.000761	0.0183	CbGeAlD
Dapsone—Sulfamethoxazole—NAT2—urinary bladder cancer	0.000701	0.239	CrCbGaD
Dapsone—CYP3A5—prostate gland—urinary bladder cancer	0.000589	0.0142	CbGeAlD
Dapsone—CYP2E1—prostate gland—urinary bladder cancer	0.00055	0.0132	CbGeAlD
Dapsone—FMO3—lymph node—urinary bladder cancer	0.000541	0.013	CbGeAlD
Dapsone—PTGS1—prostate gland—urinary bladder cancer	0.00053	0.0127	CbGeAlD
Dapsone—Proteinuria—Gemcitabine—urinary bladder cancer	0.000509	0.0158	CcSEcCtD
Dapsone—Skin exfoliation—Thiotepa—urinary bladder cancer	0.000508	0.0158	CcSEcCtD
Dapsone—PTGS2—prostate gland—urinary bladder cancer	0.000506	0.0122	CbGeAlD
Dapsone—Protein urine present—Gemcitabine—urinary bladder cancer	0.000502	0.0156	CcSEcCtD
Dapsone—CYP2E1—seminal vesicle—urinary bladder cancer	0.000465	0.0112	CbGeAlD
Dapsone—Erythema—Mitomycin—urinary bladder cancer	0.000462	0.0144	CcSEcCtD
Dapsone—PTGS1—seminal vesicle—urinary bladder cancer	0.000448	0.0108	CbGeAlD
Dapsone—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.000448	0.0139	CcSEcCtD
Dapsone—CYP2C8—renal system—urinary bladder cancer	0.000445	0.0107	CbGeAlD
Dapsone—Vision blurred—Mitomycin—urinary bladder cancer	0.000436	0.0135	CcSEcCtD
Dapsone—Abdominal pain—Valrubicin—urinary bladder cancer	0.000433	0.0134	CcSEcCtD
Dapsone—Body temperature increased—Valrubicin—urinary bladder cancer	0.000433	0.0134	CcSEcCtD
Dapsone—PTGS2—seminal vesicle—urinary bladder cancer	0.000428	0.0103	CbGeAlD
Dapsone—Skin exfoliation—Gemcitabine—urinary bladder cancer	0.000427	0.0133	CcSEcCtD
Dapsone—Cough—Mitomycin—urinary bladder cancer	0.000403	0.0125	CcSEcCtD
Dapsone—CYP3A5—renal system—urinary bladder cancer	0.000402	0.00967	CbGeAlD
Dapsone—Body temperature increased—Carboplatin—urinary bladder cancer	0.000401	0.0125	CcSEcCtD
Dapsone—Skin exfoliation—Cisplatin—urinary bladder cancer	0.000398	0.0124	CcSEcCtD
Dapsone—PTGS1—epithelium—urinary bladder cancer	0.000389	0.00937	CbGeAlD
Dapsone—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000375	0.00903	CbGeAlD
Dapsone—CYP2E1—renal system—urinary bladder cancer	0.000375	0.00902	CbGeAlD
Dapsone—PTGS2—epithelium—urinary bladder cancer	0.000372	0.00895	CbGeAlD
Dapsone—CYP2C19—vagina—urinary bladder cancer	0.000369	0.00889	CbGeAlD
Dapsone—CYP2E1—urethra—urinary bladder cancer	0.000368	0.00886	CbGeAlD
Dapsone—Skin exfoliation—Etoposide—urinary bladder cancer	0.000365	0.0113	CcSEcCtD
Dapsone—PTGS1—renal system—urinary bladder cancer	0.000361	0.00869	CbGeAlD
Dapsone—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000358	0.00863	CbGeAlD
Dapsone—CYP2C8—female reproductive system—urinary bladder cancer	0.000356	0.00858	CbGeAlD
Dapsone—MPO—lymph node—urinary bladder cancer	0.000356	0.00858	CbGeAlD
Dapsone—Vomiting—Valrubicin—urinary bladder cancer	0.000348	0.0108	CcSEcCtD
Dapsone—PTGS2—renal system—urinary bladder cancer	0.000345	0.00831	CbGeAlD
Dapsone—Headache—Valrubicin—urinary bladder cancer	0.000343	0.0107	CcSEcCtD
Dapsone—PTGS2—urethra—urinary bladder cancer	0.000339	0.00816	CbGeAlD
Dapsone—Nausea—Valrubicin—urinary bladder cancer	0.000325	0.0101	CcSEcCtD
Dapsone—CYP2C8—vagina—urinary bladder cancer	0.000322	0.00776	CbGeAlD
Dapsone—CYP2C9—female reproductive system—urinary bladder cancer	0.000317	0.00762	CbGeAlD
Dapsone—CYP3A4—renal system—urinary bladder cancer	0.000301	0.00726	CbGeAlD
Dapsone—CYP2E1—female reproductive system—urinary bladder cancer	0.0003	0.00722	CbGeAlD
Dapsone—Body temperature increased—Mitomycin—urinary bladder cancer	0.000298	0.00926	CcSEcCtD
Dapsone—CYP3A5—vagina—urinary bladder cancer	0.000291	0.007	CbGeAlD
Dapsone—PTGS1—female reproductive system—urinary bladder cancer	0.000289	0.00696	CbGeAlD
Dapsone—Albuminuria—Epirubicin—urinary bladder cancer	0.000287	0.00891	CcSEcCtD
Dapsone—Nasopharyngitis—Fluorouracil—urinary bladder cancer	0.000285	0.00887	CcSEcCtD
Dapsone—Muscular weakness—Fluorouracil—urinary bladder cancer	0.000282	0.00875	CcSEcCtD
Dapsone—Influenza—Gemcitabine—urinary bladder cancer	0.000281	0.00872	CcSEcCtD
Dapsone—PTGS2—female reproductive system—urinary bladder cancer	0.000276	0.00665	CbGeAlD
Dapsone—Nasopharyngitis—Cisplatin—urinary bladder cancer	0.000271	0.00841	CcSEcCtD
Dapsone—Albuminuria—Doxorubicin—urinary bladder cancer	0.000265	0.00824	CcSEcCtD
Dapsone—PTGS1—vagina—urinary bladder cancer	0.000261	0.00629	CbGeAlD
Dapsone—Proteinuria—Methotrexate—urinary bladder cancer	0.00026	0.00809	CcSEcCtD
Dapsone—Protein urine present—Methotrexate—urinary bladder cancer	0.000257	0.00798	CcSEcCtD
Dapsone—Pancreatitis—Cisplatin—urinary bladder cancer	0.000256	0.00797	CcSEcCtD
Dapsone—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.000252	0.00782	CcSEcCtD
Dapsone—PTGS2—vagina—urinary bladder cancer	0.00025	0.00602	CbGeAlD
Dapsone—Tinnitus—Thiotepa—urinary bladder cancer	0.000249	0.00773	CcSEcCtD
Dapsone—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.000245	0.00762	CcSEcCtD
Dapsone—CYP3A4—female reproductive system—urinary bladder cancer	0.000241	0.00581	CbGeAlD
Dapsone—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.000241	0.00749	CcSEcCtD
Dapsone—Vomiting—Mitomycin—urinary bladder cancer	0.00024	0.00745	CcSEcCtD
Dapsone—Headache—Mitomycin—urinary bladder cancer	0.000236	0.00734	CcSEcCtD
Dapsone—Erythema—Thiotepa—urinary bladder cancer	0.000232	0.00722	CcSEcCtD
Dapsone—Sinusitis—Fluorouracil—urinary bladder cancer	0.000231	0.00717	CcSEcCtD
Dapsone—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.000229	0.0071	CcSEcCtD
Dapsone—Nausea—Mitomycin—urinary bladder cancer	0.000224	0.00696	CcSEcCtD
Dapsone—Pharyngitis—Gemcitabine—urinary bladder cancer	0.000223	0.00693	CcSEcCtD
Dapsone—Pharyngitis—Fluorouracil—urinary bladder cancer	0.000219	0.00681	CcSEcCtD
Dapsone—Vision blurred—Thiotepa—urinary bladder cancer	0.000219	0.00681	CcSEcCtD
Dapsone—Skin exfoliation—Methotrexate—urinary bladder cancer	0.000218	0.00679	CcSEcCtD
Dapsone—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.000209	0.00651	CcSEcCtD
Dapsone—Skin exfoliation—Epirubicin—urinary bladder cancer	0.000204	0.00635	CcSEcCtD
Dapsone—Cough—Thiotepa—urinary bladder cancer	0.000203	0.0063	CcSEcCtD
Dapsone—Erythema—Gemcitabine—urinary bladder cancer	0.000196	0.00607	CcSEcCtD
Dapsone—Tinnitus—Cisplatin—urinary bladder cancer	0.000195	0.00606	CcSEcCtD
Dapsone—Erythema—Fluorouracil—urinary bladder cancer	0.000192	0.00597	CcSEcCtD
Dapsone—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.000189	0.00588	CcSEcCtD
Dapsone—Tachycardia—Thiotepa—urinary bladder cancer	0.000185	0.00575	CcSEcCtD
Dapsone—Erythema—Cisplatin—urinary bladder cancer	0.000182	0.00566	CcSEcCtD
Dapsone—Vision blurred—Fluorouracil—urinary bladder cancer	0.000181	0.00563	CcSEcCtD
Dapsone—Vision blurred—Cisplatin—urinary bladder cancer	0.000172	0.00534	CcSEcCtD
Dapsone—Cough—Gemcitabine—urinary bladder cancer	0.000171	0.0053	CcSEcCtD
Dapsone—PTGS1—lymph node—urinary bladder cancer	0.000169	0.00407	CbGeAlD
Dapsone—PTGS2—lymph node—urinary bladder cancer	0.000162	0.00389	CbGeAlD
Dapsone—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000155	0.00482	CcSEcCtD
Dapsone—Tachycardia—Fluorouracil—urinary bladder cancer	0.000153	0.00476	CcSEcCtD
Dapsone—Vertigo—Etoposide—urinary bladder cancer	0.00015	0.00466	CcSEcCtD
Dapsone—Abdominal pain—Thiotepa—urinary bladder cancer	0.00015	0.00466	CcSEcCtD
Dapsone—Body temperature increased—Thiotepa—urinary bladder cancer	0.00015	0.00466	CcSEcCtD
Dapsone—Cough—Etoposide—urinary bladder cancer	0.000146	0.00453	CcSEcCtD
Dapsone—Tachycardia—Cisplatin—urinary bladder cancer	0.000145	0.00451	CcSEcCtD
Dapsone—Insomnia—Gemcitabine—urinary bladder cancer	0.000144	0.00448	CcSEcCtD
Dapsone—Insomnia—Fluorouracil—urinary bladder cancer	0.000142	0.00441	CcSEcCtD
Dapsone—Pancreatitis—Methotrexate—urinary bladder cancer	0.000141	0.00437	CcSEcCtD
Dapsone—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000139	0.00432	CcSEcCtD
Dapsone—Muscular weakness—Epirubicin—urinary bladder cancer	0.000137	0.00426	CcSEcCtD
Dapsone—Influenza—Epirubicin—urinary bladder cancer	0.000134	0.00417	CcSEcCtD
Dapsone—Tachycardia—Etoposide—urinary bladder cancer	0.000133	0.00413	CcSEcCtD
Dapsone—Pancreatitis—Epirubicin—urinary bladder cancer	0.000132	0.00409	CcSEcCtD
Dapsone—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000131	0.00407	CcSEcCtD
Dapsone—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000129	0.004	CcSEcCtD
Dapsone—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000127	0.00394	CcSEcCtD
Dapsone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000126	0.00392	CcSEcCtD
Dapsone—Influenza—Doxorubicin—urinary bladder cancer	0.000124	0.00386	CcSEcCtD
Dapsone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000124	0.00385	CcSEcCtD
Dapsone—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000123	0.00381	CcSEcCtD
Dapsone—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000122	0.00379	CcSEcCtD
Dapsone—Vomiting—Thiotepa—urinary bladder cancer	0.000121	0.00375	CcSEcCtD
Dapsone—Headache—Thiotepa—urinary bladder cancer	0.000119	0.00369	CcSEcCtD
Dapsone—Body temperature increased—Cisplatin—urinary bladder cancer	0.000118	0.00365	CcSEcCtD
Dapsone—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000117	0.00365	CcSEcCtD
Dapsone—Pharyngitis—Methotrexate—urinary bladder cancer	0.000114	0.00354	CcSEcCtD
Dapsone—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000113	0.00352	CcSEcCtD
Dapsone—Nausea—Thiotepa—urinary bladder cancer	0.000113	0.0035	CcSEcCtD
Dapsone—Sinusitis—Epirubicin—urinary bladder cancer	0.000112	0.00349	CcSEcCtD
Dapsone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000111	0.00346	CcSEcCtD
Dapsone—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000109	0.00337	CcSEcCtD
Dapsone—Body temperature increased—Etoposide—urinary bladder cancer	0.000108	0.00335	CcSEcCtD
Dapsone—Abdominal pain—Etoposide—urinary bladder cancer	0.000108	0.00335	CcSEcCtD
Dapsone—Tinnitus—Methotrexate—urinary bladder cancer	0.000107	0.00333	CcSEcCtD
Dapsone—Pharyngitis—Epirubicin—urinary bladder cancer	0.000107	0.00332	CcSEcCtD
Dapsone—Sinusitis—Doxorubicin—urinary bladder cancer	0.000104	0.00323	CcSEcCtD
Dapsone—Vomiting—Gemcitabine—urinary bladder cancer	0.000101	0.00315	CcSEcCtD
Dapsone—Tinnitus—Epirubicin—urinary bladder cancer	0.0001	0.00311	CcSEcCtD
Dapsone—Erythema—Methotrexate—urinary bladder cancer	0.0001	0.00311	CcSEcCtD
Dapsone—Headache—Gemcitabine—urinary bladder cancer	0.0001	0.00311	CcSEcCtD
Dapsone—Vomiting—Fluorouracil—urinary bladder cancer	9.97e-05	0.0031	CcSEcCtD
Dapsone—Pharyngitis—Doxorubicin—urinary bladder cancer	9.87e-05	0.00307	CcSEcCtD
Dapsone—Headache—Fluorouracil—urinary bladder cancer	9.83e-05	0.00305	CcSEcCtD
Dapsone—Nausea—Gemcitabine—urinary bladder cancer	9.48e-05	0.00294	CcSEcCtD
Dapsone—Vomiting—Cisplatin—urinary bladder cancer	9.46e-05	0.00294	CcSEcCtD
Dapsone—Vision blurred—Methotrexate—urinary bladder cancer	9.42e-05	0.00293	CcSEcCtD
Dapsone—Erythema—Epirubicin—urinary bladder cancer	9.36e-05	0.00291	CcSEcCtD
Dapsone—Nausea—Fluorouracil—urinary bladder cancer	9.32e-05	0.0029	CcSEcCtD
Dapsone—Tinnitus—Doxorubicin—urinary bladder cancer	9.27e-05	0.00288	CcSEcCtD
Dapsone—Vertigo—Methotrexate—urinary bladder cancer	8.98e-05	0.00279	CcSEcCtD
Dapsone—Nausea—Cisplatin—urinary bladder cancer	8.83e-05	0.00274	CcSEcCtD
Dapsone—Vision blurred—Epirubicin—urinary bladder cancer	8.82e-05	0.00274	CcSEcCtD
Dapsone—Cough—Methotrexate—urinary bladder cancer	8.73e-05	0.00271	CcSEcCtD
Dapsone—Vomiting—Etoposide—urinary bladder cancer	8.66e-05	0.00269	CcSEcCtD
Dapsone—Erythema—Doxorubicin—urinary bladder cancer	8.66e-05	0.00269	CcSEcCtD
Dapsone—Headache—Etoposide—urinary bladder cancer	8.54e-05	0.00265	CcSEcCtD
Dapsone—Vertigo—Epirubicin—urinary bladder cancer	8.41e-05	0.00261	CcSEcCtD
Dapsone—Cough—Epirubicin—urinary bladder cancer	8.17e-05	0.00254	CcSEcCtD
Dapsone—Vision blurred—Doxorubicin—urinary bladder cancer	8.16e-05	0.00254	CcSEcCtD
Dapsone—Nausea—Etoposide—urinary bladder cancer	8.09e-05	0.00251	CcSEcCtD
Dapsone—Vertigo—Doxorubicin—urinary bladder cancer	7.78e-05	0.00242	CcSEcCtD
Dapsone—Cough—Doxorubicin—urinary bladder cancer	7.56e-05	0.00235	CcSEcCtD
Dapsone—Tachycardia—Epirubicin—urinary bladder cancer	7.45e-05	0.00232	CcSEcCtD
Dapsone—Insomnia—Methotrexate—urinary bladder cancer	7.38e-05	0.00229	CcSEcCtD
Dapsone—Insomnia—Epirubicin—urinary bladder cancer	6.91e-05	0.00215	CcSEcCtD
Dapsone—Tachycardia—Doxorubicin—urinary bladder cancer	6.9e-05	0.00214	CcSEcCtD
Dapsone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	6.67e-05	0.00207	CcSEcCtD
Dapsone—Abdominal pain—Methotrexate—urinary bladder cancer	6.45e-05	0.002	CcSEcCtD
Dapsone—Body temperature increased—Methotrexate—urinary bladder cancer	6.45e-05	0.002	CcSEcCtD
Dapsone—Insomnia—Doxorubicin—urinary bladder cancer	6.39e-05	0.00199	CcSEcCtD
Dapsone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	6.25e-05	0.00194	CcSEcCtD
Dapsone—Body temperature increased—Epirubicin—urinary bladder cancer	6.04e-05	0.00188	CcSEcCtD
Dapsone—Abdominal pain—Epirubicin—urinary bladder cancer	6.04e-05	0.00188	CcSEcCtD
Dapsone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	5.78e-05	0.0018	CcSEcCtD
Dapsone—Abdominal pain—Doxorubicin—urinary bladder cancer	5.59e-05	0.00174	CcSEcCtD
Dapsone—Body temperature increased—Doxorubicin—urinary bladder cancer	5.59e-05	0.00174	CcSEcCtD
Dapsone—Vomiting—Methotrexate—urinary bladder cancer	5.19e-05	0.00161	CcSEcCtD
Dapsone—Headache—Methotrexate—urinary bladder cancer	5.11e-05	0.00159	CcSEcCtD
Dapsone—Vomiting—Epirubicin—urinary bladder cancer	4.86e-05	0.00151	CcSEcCtD
Dapsone—Nausea—Methotrexate—urinary bladder cancer	4.85e-05	0.00151	CcSEcCtD
Dapsone—Headache—Epirubicin—urinary bladder cancer	4.78e-05	0.00149	CcSEcCtD
Dapsone—Nausea—Epirubicin—urinary bladder cancer	4.54e-05	0.00141	CcSEcCtD
Dapsone—Vomiting—Doxorubicin—urinary bladder cancer	4.49e-05	0.0014	CcSEcCtD
Dapsone—Headache—Doxorubicin—urinary bladder cancer	4.43e-05	0.00138	CcSEcCtD
Dapsone—Nausea—Doxorubicin—urinary bladder cancer	4.2e-05	0.0013	CcSEcCtD
Dapsone—FMO3—Metabolism—CREBBP—urinary bladder cancer	1.28e-05	0.000148	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	1.28e-05	0.000148	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—RRM2—urinary bladder cancer	1.27e-05	0.000147	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.27e-05	0.000147	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PTEN—urinary bladder cancer	1.26e-05	0.000146	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.24e-05	0.000144	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.24e-05	0.000144	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GSTP1—urinary bladder cancer	1.23e-05	0.000142	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—TYMP—urinary bladder cancer	1.22e-05	0.000141	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ENO2—urinary bladder cancer	1.22e-05	0.000141	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	1.22e-05	0.000141	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—TYMP—urinary bladder cancer	1.22e-05	0.000141	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	1.21e-05	0.00014	CbGpPWpGaD
Dapsone—NAT2—Metabolism—EP300—urinary bladder cancer	1.2e-05	0.000139	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.18e-05	0.000137	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	1.18e-05	0.000136	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ENO2—urinary bladder cancer	1.18e-05	0.000136	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—HPGDS—urinary bladder cancer	1.18e-05	0.000136	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	1.18e-05	0.000136	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.17e-05	0.000136	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.17e-05	0.000136	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—NAT2—urinary bladder cancer	1.17e-05	0.000135	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.16e-05	0.000135	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GSTT1—urinary bladder cancer	1.14e-05	0.000132	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—TYMS—urinary bladder cancer	1.14e-05	0.000132	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GSTM1—urinary bladder cancer	1.13e-05	0.000131	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—NCOR1—urinary bladder cancer	1.13e-05	0.000131	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.13e-05	0.00013	CbGpPWpGaD
Dapsone—PTGS2—Disease—ENO2—urinary bladder cancer	1.12e-05	0.000129	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—NAT2—urinary bladder cancer	1.1e-05	0.000127	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.1e-05	0.000127	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—NAT2—urinary bladder cancer	1.1e-05	0.000127	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GPX1—urinary bladder cancer	1.08e-05	0.000125	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.07e-05	0.000124	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—ERCC2—urinary bladder cancer	1.06e-05	0.000123	CbGpPWpGaD
Dapsone—PTGS2—Disease—RBX1—urinary bladder cancer	1.06e-05	0.000122	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.06e-05	0.000122	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.05e-05	0.000122	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PTGS2—urinary bladder cancer	1.05e-05	0.000121	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.04e-05	0.000121	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.01e-05	0.000117	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—RRM2—urinary bladder cancer	1.01e-05	0.000117	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—MTHFR—urinary bladder cancer	9.98e-06	0.000116	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	9.84e-06	0.000114	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—NQO1—urinary bladder cancer	9.8e-06	0.000113	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—NAT2—urinary bladder cancer	9.52e-06	0.00011	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—RRM2—urinary bladder cancer	9.51e-06	0.00011	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—NQO1—urinary bladder cancer	9.5e-06	0.00011	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—RRM2—urinary bladder cancer	9.49e-06	0.00011	CbGpPWpGaD
Dapsone—PTGS2—Disease—JAG1—urinary bladder cancer	9.48e-06	0.00011	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.42e-06	0.000109	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—TYMP—urinary bladder cancer	9.4e-06	0.000109	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—HPGDS—urinary bladder cancer	9.35e-06	0.000108	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ENO2—urinary bladder cancer	9.35e-06	0.000108	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	9.33e-06	0.000108	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	9.33e-06	0.000108	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.3e-06	0.000108	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.22e-06	0.000107	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PTEN—urinary bladder cancer	9.12e-06	0.000106	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GSTT1—urinary bladder cancer	9.07e-06	0.000105	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.03e-06	0.000104	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.93e-06	0.000103	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ENO2—urinary bladder cancer	8.81e-06	0.000102	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	8.81e-06	0.000102	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ENO2—urinary bladder cancer	8.79e-06	0.000102	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	8.79e-06	0.000102	CbGpPWpGaD
Dapsone—FMO3—Metabolism—EP300—urinary bladder cancer	8.7e-06	0.000101	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.59e-06	9.94e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—TYMP—urinary bladder cancer	8.57e-06	9.91e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	8.54e-06	9.88e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	8.53e-06	9.87e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	8.52e-06	9.86e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—NAT2—urinary bladder cancer	8.5e-06	9.83e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.23e-06	9.52e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—RRM2—urinary bladder cancer	8.22e-06	9.51e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	8.17e-06	9.45e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PPARG—urinary bladder cancer	8.1e-06	9.37e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.04e-06	9.3e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GSTP1—urinary bladder cancer	7.92e-06	9.16e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CREBBP—urinary bladder cancer	7.78e-06	9e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	7.75e-06	8.96e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	7.68e-06	8.89e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.66e-06	8.87e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	7.61e-06	8.81e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	7.61e-06	8.81e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—TYMS—urinary bladder cancer	7.6e-06	8.79e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.57e-06	8.75e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—NQO1—urinary bladder cancer	7.54e-06	8.72e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	7.51e-06	8.69e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	7.51e-06	8.69e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	7.38e-06	8.54e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—TYMS—urinary bladder cancer	7.36e-06	8.52e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—RRM2—urinary bladder cancer	7.34e-06	8.49e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GSTM1—urinary bladder cancer	7.28e-06	8.42e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—NCOR1—urinary bladder cancer	7.28e-06	8.42e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.27e-06	8.41e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	7.25e-06	8.39e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GPX1—urinary bladder cancer	7.19e-06	8.32e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—NQO1—urinary bladder cancer	7.1e-06	8.21e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	7.08e-06	8.19e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	7.07e-06	8.18e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	7.06e-06	8.17e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GPX1—urinary bladder cancer	6.97e-06	8.06e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—NCOR1—urinary bladder cancer	6.9e-06	7.98e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ERCC2—urinary bladder cancer	6.84e-06	7.92e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ENO2—urinary bladder cancer	6.79e-06	7.86e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	6.79e-06	7.86e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.75e-06	7.81e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	6.69e-06	7.74e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	6.64e-06	7.68e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	6.59e-06	7.62e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.49e-06	7.51e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—ERCC2—urinary bladder cancer	6.49e-06	7.51e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—MTHFR—urinary bladder cancer	6.43e-06	7.44e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.38e-06	7.38e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PTGS2—urinary bladder cancer	6.37e-06	7.37e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GSTP1—urinary bladder cancer	6.29e-06	7.28e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	6.19e-06	7.17e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	6.19e-06	7.17e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.16e-06	7.12e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	6.14e-06	7.1e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MTHFR—urinary bladder cancer	6.1e-06	7.06e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.08e-06	7.04e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—TERT—urinary bladder cancer	6.08e-06	7.04e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	6.01e-06	6.95e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.95e-06	6.89e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	5.92e-06	6.85e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.92e-06	6.84e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	5.91e-06	6.83e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—TYMS—urinary bladder cancer	5.85e-06	6.76e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—NCOR1—urinary bladder cancer	5.78e-06	6.69e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GSTM1—urinary bladder cancer	5.78e-06	6.69e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	5.65e-06	6.54e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—FGFR3—urinary bladder cancer	5.58e-06	6.46e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PTEN—urinary bladder cancer	5.55e-06	6.43e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GPX1—urinary bladder cancer	5.53e-06	6.4e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—TYMS—urinary bladder cancer	5.5e-06	6.37e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	5.49e-06	6.35e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—NQO1—urinary bladder cancer	5.48e-06	6.34e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	5.44e-06	6.29e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	5.44e-06	6.29e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ERCC2—urinary bladder cancer	5.43e-06	6.29e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	5.43e-06	6.28e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	5.43e-06	6.28e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PPARG—urinary bladder cancer	5.38e-06	6.23e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.31e-06	6.15e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—EP300—urinary bladder cancer	5.3e-06	6.13e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PPARG—urinary bladder cancer	5.22e-06	6.04e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GPX1—urinary bladder cancer	5.21e-06	6.03e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	5.2e-06	6.01e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.19e-06	6.01e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	5.17e-06	5.98e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	5.12e-06	5.92e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	5.11e-06	5.92e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	5.11e-06	5.91e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—MTHFR—urinary bladder cancer	5.11e-06	5.91e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	5.1e-06	5.9e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CREBBP—urinary bladder cancer	5.01e-06	5.8e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	4.99e-06	5.78e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.95e-06	5.73e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.84e-06	5.6e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	4.81e-06	5.56e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	4.8e-06	5.55e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	4.76e-06	5.5e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—CREBBP—urinary bladder cancer	4.75e-06	5.5e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	4.7e-06	5.44e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	4.7e-06	5.44e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.63e-06	5.36e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	4.57e-06	5.28e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	4.5e-06	5.21e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	4.42e-06	5.11e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.42e-06	5.11e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	4.41e-06	5.1e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—RHOA—urinary bladder cancer	4.3e-06	4.97e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—TYMS—urinary bladder cancer	4.25e-06	4.91e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	4.23e-06	4.9e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.22e-06	4.89e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	4.2e-06	4.86e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	4.2e-06	4.86e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	4.16e-06	4.82e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	4.16e-06	4.81e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PPARG—urinary bladder cancer	4.14e-06	4.79e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTGS2—urinary bladder cancer	4.1e-06	4.75e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	4.09e-06	4.73e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	4.09e-06	4.73e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.03e-06	4.66e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GPX1—urinary bladder cancer	4.02e-06	4.65e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CREBBP—urinary bladder cancer	3.98e-06	4.6e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—ERBB2—urinary bladder cancer	3.98e-06	4.6e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.96e-06	4.58e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	3.95e-06	4.57e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PPARG—urinary bladder cancer	3.9e-06	4.51e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.89e-06	4.5e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	3.87e-06	4.48e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	3.83e-06	4.43e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	3.83e-06	4.43e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	3.75e-06	4.33e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	3.74e-06	4.32e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	3.71e-06	4.29e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTEN—urinary bladder cancer	3.69e-06	4.27e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	3.66e-06	4.24e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	3.6e-06	4.16e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTEN—urinary bladder cancer	3.58e-06	4.14e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—EP300—urinary bladder cancer	3.52e-06	4.07e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—EP300—urinary bladder cancer	3.41e-06	3.95e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—CDKN1A—urinary bladder cancer	3.4e-06	3.93e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—PTEN—urinary bladder cancer	3.39e-06	3.92e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	3.38e-06	3.91e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	3.37e-06	3.9e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.29e-06	3.81e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	3.24e-06	3.75e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—EP300—urinary bladder cancer	3.24e-06	3.74e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—SRC—urinary bladder cancer	3.15e-06	3.64e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	3.07e-06	3.55e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	3.06e-06	3.54e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.01e-06	3.48e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.89e-06	3.34e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PTEN—urinary bladder cancer	2.84e-06	3.29e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MYC—urinary bladder cancer	2.82e-06	3.26e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—EGFR—urinary bladder cancer	2.76e-06	3.19e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.75e-06	3.18e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.74e-06	3.17e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—EP300—urinary bladder cancer	2.71e-06	3.13e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTEN—urinary bladder cancer	2.67e-06	3.09e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.67e-06	3.09e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	2.65e-06	3.07e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.63e-06	3.05e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—KRAS—urinary bladder cancer	2.61e-06	3.01e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.55e-06	2.95e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—EP300—urinary bladder cancer	2.55e-06	2.95e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.55e-06	2.94e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.52e-06	2.92e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.52e-06	2.92e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.37e-06	2.75e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.37e-06	2.74e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.31e-06	2.67e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.23e-06	2.58e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—HRAS—urinary bladder cancer	2.21e-06	2.56e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.2e-06	2.55e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.16e-06	2.5e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.06e-06	2.39e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.97e-06	2.28e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.88e-06	2.18e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.81e-06	2.09e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.79e-06	2.08e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.74e-06	2.01e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.42e-06	1.65e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.24e-06	1.44e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.18e-06	1.37e-05	CbGpPWpGaD
